Diagnosis of Sarcopenia in Older Adults

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NICE · May 30, 2025

Keywords

ClinConnect Summary

This clinical trial is studying sarcopenia, which is the loss of muscle strength and mass that often occurs as people age. Sarcopenia can lead to frailty and impact an older person's ability to live independently. The trial aims to evaluate a new device called the Biody XpertZM3, which measures muscle mass in a seated position, making the testing process easier and more comfortable for older adults compared to traditional methods that require lying down.

To participate in the trial, you need to be 60 years or older and receiving care at specific centers that focus on rehabilitation and aging. You should also be covered by a social security system and be able to provide informed consent. However, individuals with certain conditions, like having a pacemaker or other electronic devices, or specific health issues that affect measurements, will not be eligible. Participants will undergo a simple and quick muscle mass assessment, and this study will help improve how sarcopenia is diagnosed in the future, ultimately benefiting older adults as they age.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Men or women aged 60 or over already receiving care at the Day Hospital of the Rehabilitation, Independence and Aging Center or the Frailty Platform of the Rehabilitation, Independence and Aging Center.
• • Patients affiliated with or covered by a social security system.
• • Patients who have signed an informed consent form in advance.
• Exclusion Criteria:
• • Vulnerable persons as defined in Articles L1121-5 to -8
• • People with pacemakers, implantable defibrillators, or other electronic medical devices
• • Musculoskeletal disorders that prevent bioimpedance measurement in a seated position
• • Any condition of fluid retention or dehydration
• • Absence of a measurement site (muscle resection or amputation)